Non-Small Cell Lung Carcinoma | Squamous cell carcinoma | Adenocarcinoma | Carcinoma, Large Cell | Type Mixed
Item
histologically confirmed non-small cell lung cancer, the pathology type includes squamous cell carcinoma, adenocarcinoma, large-cell carcinoma, and any mixed type of the 3 types mentioned above.
boolean
C0007131 (UMLS CUI [1])
C0007137 (UMLS CUI [2])
C0001418 (UMLS CUI [3])
C0206704 (UMLS CUI [4])
C0332307 (UMLS CUI [5,1])
C0205430 (UMLS CUI [5,2])
Non-Small Cell Lung Carcinoma TNM clinical staging | Tumor Complete excision | Type Operative Surgical Procedures | Lobectomy | LUNG LEFT PNEUMONECTOMY | Bilobectomy of lung
Item
stage ib-iiia non-small cell lung cancer, tumor was completely resected (the type of surgery including lobectomy, left side pneumonectomy,bi-lobectomy).
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0027651 (UMLS CUI [2,1])
C0015250 (UMLS CUI [2,2])
C0332307 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
C0023928 (UMLS CUI [4])
C0746125 (UMLS CUI [5])
C0396580 (UMLS CUI [6])
Timespan Operative Surgical Procedures Adjuvant Chemotherapy
Item
the time from surgery to first dose of adjuvant chemotherapy are mandatory between 4-8 weeks.
boolean
C0872291 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C0085533 (UMLS CUI [1,3])
Absence Recurrent tumor prior to Adjuvant therapy
Item
no evidence of tumor relapse prior to adjuvant therapy.
boolean
C0332197 (UMLS CUI [1,1])
C0521158 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0677850 (UMLS CUI [1,4])
Age | ECOG performance status
Item
age 18-70, eastern cooperative oncology group(ecog) performance status 0-1.
boolean
C0001779 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
Hematologic function | Renal function | Liver function | Cardiac function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
normal hematologic function.renal function , hepatic and cardiac function will be within the acceptable ranges as following:serum bilirubin, aspartate aminotransferase(ast)and alamine aminotransferase(alt)levels below 1.5 times of normal value.
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0232164 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
Chemotherapy Absent | Therapeutic radiology procedure Absent
Item
no history of chemotherapy or radiotherapy;
boolean
C0392920 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Compliance behavior Chemotherapy | Compliance behavior Follow-up
Item
the patient should have well compliance for chemotherapy and follow up
boolean
C1321605 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C3274571 (UMLS CUI [2,2])
Informed Consent
Item
informed consent should be obtained before treatment.
boolean
C0021430 (UMLS CUI [1])
Documents Histologic Mismatch Inclusion criteria | Documents Cytologic Mismatch Inclusion criteria
Item
the histological or cytological documents do not match the inclusion criteria.
boolean
C1301746 (UMLS CUI [1,1])
C0205462 (UMLS CUI [1,2])
C1881865 (UMLS CUI [1,3])
C1512693 (UMLS CUI [1,4])
C1301746 (UMLS CUI [2,1])
C0205471 (UMLS CUI [2,2])
C1881865 (UMLS CUI [2,3])
C1512693 (UMLS CUI [2,4])
LUNG RIGHT PNEUMONECTOMY | Incomplete Resection
Item
right side pneumonectomy or any kind of incompletely resected surgery.
boolean
C0746225 (UMLS CUI [1])
C4330937 (UMLS CUI [2])
Timespan Patient Recruitment Operative Surgical Procedures
Item
the recruitment time are beyond 8 weeks from surgery.
boolean
C0872291 (UMLS CUI [1,1])
C0242800 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,3])
Systemic disease At risk Clinical Trial | Systemic disease chronic At risk Clinical Trial | Mental disorders At risk Clinical Trial | Systemic disease At risk Therapeutic procedure | Systemic disease chronic At risk Therapeutic procedure | Mental disorders At risk Therapeutic procedure | Systemic disease Influence Research results Analysis | Systemic disease chronic Influence Research results Analysis | Mental disorders Influence Research results Analysis | Uncontrolled hypertension | Angina, Unstable | Myocardial Infarction | Cardiac Arrhythmia Uncontrolled | Symptomatic congestive heart failure | Anemia Electrocardiography | Heart valve disease | Bacterial Infections | Virus Diseases | Mycoses | Cardiac Arrhythmia Grade | Anemia Myocardial Grade | Cardiac Troponin T Abnormal CTCAE Grades | Hypertensive disease Grade | Left ventricular ejection fraction
Item
any concurrent acute or chronic systemic diseases or psychiatric diseases, which might both increase the risks of the research itself or the medical therapy and influence the research results analysis. the researchers can make a judge for the following conditions to tell whether they are fit for this research:uncontrolled high blood pressure, unstable angina , myocardial infarction , uncontrolled arrhythmia,or congestive heart failure with clinical symptoms within 12 weeks before randomization.evidence of anemia from electrocardiographic manifestation or heart valve disease with confirmed clinical diagnosis.clinically significant active infection state due to bacteria, virus and fungi invasion. patients with grade ii arrhythmia, grade ii myocardial anemia, grade ii abnormal cardiac troponin t, grade ii high blood pressure or left ventricle ejection fraction (lvef) less than 50 percent according to ctc 3.0 are not permitted to enrol the study.
boolean
C0442893 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0442893 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0004936 (UMLS CUI [3,1])
C1444641 (UMLS CUI [3,2])
C0008976 (UMLS CUI [3,3])
C0442893 (UMLS CUI [4,1])
C1444641 (UMLS CUI [4,2])
C0087111 (UMLS CUI [4,3])
C0442893 (UMLS CUI [5,1])
C0205191 (UMLS CUI [5,2])
C1444641 (UMLS CUI [5,3])
C0087111 (UMLS CUI [5,4])
C0004936 (UMLS CUI [6,1])
C1444641 (UMLS CUI [6,2])
C0087111 (UMLS CUI [6,3])
C0442893 (UMLS CUI [7,1])
C4054723 (UMLS CUI [7,2])
C0683954 (UMLS CUI [7,3])
C0936012 (UMLS CUI [7,4])
C0442893 (UMLS CUI [8,1])
C0205191 (UMLS CUI [8,2])
C4054723 (UMLS CUI [8,3])
C0683954 (UMLS CUI [8,4])
C0936012 (UMLS CUI [8,5])
C0004936 (UMLS CUI [9,1])
C4054723 (UMLS CUI [9,2])
C0683954 (UMLS CUI [9,3])
C0936012 (UMLS CUI [9,4])
C1868885 (UMLS CUI [10])
C0002965 (UMLS CUI [11])
C0027051 (UMLS CUI [12])
C0003811 (UMLS CUI [13,1])
C0205318 (UMLS CUI [13,2])
C0742758 (UMLS CUI [14])
C0002871 (UMLS CUI [15,1])
C1623258 (UMLS CUI [15,2])
C0018824 (UMLS CUI [16])
C0004623 (UMLS CUI [17])
C0042769 (UMLS CUI [18])
C0026946 (UMLS CUI [19])
C0003811 (UMLS CUI [20,1])
C0441800 (UMLS CUI [20,2])
C0002871 (UMLS CUI [21,1])
C1522564 (UMLS CUI [21,2])
C0441800 (UMLS CUI [21,3])
C3538889 (UMLS CUI [22,1])
C0205161 (UMLS CUI [22,2])
C1516728 (UMLS CUI [22,3])
C0020538 (UMLS CUI [23,1])
C0441800 (UMLS CUI [23,2])
C0428772 (UMLS CUI [24])
Pregnancy | Breast Feeding
Item
women with pregnant or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cancer Other | Exception Skin carcinoma | Exception Carcinoma in Situ | Exception Prostate carcinoma Early stage Cured
Item
before enter the group,the patients had other malignant tumors except for non-melanoma skin cancer, carcinoma in situ and cured early-stage prostate cancer.
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0007099 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0600139 (UMLS CUI [4,2])
C2363430 (UMLS CUI [4,3])
C1880198 (UMLS CUI [4,4])
Hypersensitivity Investigational New Drugs | Allergic Reaction Possible Investigational New Drugs
Item
with allergic constitution or possible allergic reflection to any known research drugs.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0332149 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
Poor compliance
Item
poor compliance.
boolean
C0032646 (UMLS CUI [1])
Study Subject Participation Status Inappropriate
Item
not proper for the research according to the researchers' judgment.
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])